Professor, Marmara University Turkey
Dr. Ahmet Özen is the Chief of the Division of Allergy and Immunology in Pediatrics at Marmara University and Director of the Istanbul Jeffrey Modell Center for Primary Immune Deficiencies. A distinguished researcher, he is renowned for discovering genetic mutations linked to immune dysregulation and CHAPLE disease, leading to FDA approval of pozelimab. With a career dedicated to translational medicine, Dr. Özen founded the Marmara University Işıl Berat Barlan Center for Translational Medicine and plays an active role in the NIAID-MENAT Strategy for Enhanced Research Engagement Program. His groundbreaking work on monogenic IBD networks in Türkiye has shaped new therapeutic pathways, benefiting countless patients globally.
Publication Profile
Google Scholar
🎓 Education
M.D. in Medicine, Marmara University, Istanbul (2000) Residency: Pediatrics, Marmara University (2005) Fellowship: Pediatric Allergy and Immunology, Yeditepe University (2012). Postdoctoral Research: Lab of Immunology, NIAID, NIH, Bethesda, MD (2016) Dr. Özen’s educational journey spans prestigious institutions, where he developed expertise in immunology, pediatrics, and translational medicine. His NIH fellowship catalyzed significant research in immune dysregulation and CHAPLE disease.
💼 Experience
2016–Present: Chief, Division of Allergy & Immunology, Marmara University. 2016–Present: Director, Istanbul Jeffrey Modell Center. 2020–Present: Founder, Işıl Berat Barlan Center for Translational Medicine Dr. Özen’s professional roles reflect leadership in clinical care, research, and education. His transformative contributions to pediatric immunology, particularly through international collaborations, have advanced global health initiatives.
🏆 Awards & Honors
2021: EFIS Diversity Task Force Publication Award. 2021: Turkish Council of Higher Education Award for Excellence in International Collaborations. 2022: Aziz Sancar Award, Health Institutes of Türkiye. 2024: EFIS Eastern Star Award Dr. Özen’s accolades recognize his outstanding achievements in immunological research, collaborations, and pioneering clinical applications.
🔬 Research Focus
Dr. Özen specializes in immune dysregulation, monogenic IBD, and CHAPLE disease. His work includes identifying gene mutations (e.g., CD55, IL37, ST6Galnac1), exploring complement hyperactivation pathways, and developing targeted therapies. His contributions to translational medicine and precision therapy have set benchmarks in pediatric allergy and immunology.
Conclusion
Dr. Özen’s unparalleled achievements in pediatric immunology, combined with his visionary leadership, make him an exemplary researcher deserving of recognition. His commitment to translating complex immunological findings into therapeutic innovations underscores his profound influence on the field. Recognizing Dr. Özen with the Best Researcher Award would not only honor his past accomplishments but also inspire continued excellence and advancement in pediatric allergy and immunology research.
Publication Top Notes